Results 181 to 190 of about 138,294 (305)

Pulmonary mucormycosis and <i>Achromobacter xylosoxidans</i> co-infection in an immunocompromised host: a case report. [PDF]

Ann Med Surg (Lond)
Subedi B, Gautam N, Upadhyay A, Sharma M, Bitetto D.   +4 more
europepmc   +1 more source

Kataláz aktivitás vizsgálata a Rhizopus oryzae opportunista patogén járomspórás gombában [PDF]

, 2012
Linka Beáta
core  

Pan‐European Fragile Populations Cohort for COVID‐19: What Worked, What Didn't, and Lessons Learned

Transplant Infectious Disease, EarlyView.
ABSTRACT The COVID‐19 pandemic exposed the vulnerability of immunocompromised hosts and the scarcity of evidence guiding their management. Within the European Horizon 2020 ORCHESTRA project, a multinational consortium connected existing and new cohorts to harmonize data, laboratory methods, and clinical expertise across fragile populations. The fragile
Beatrice Tazza, Cecilia Bonazzetti, Natascia Caroccia, Michela Di Chiara, Lorenzo Maria Canziani, Anna Maria Azzini, Zaira R. Palacios‐Baena, Paula Olivares‐Navarro, Jesús Rodríguez‐Baño, Evelina Tacconelli, Pierluigi Viale, Maddalena Giannella   +11 more
wiley   +1 more source

Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy. [PDF]

Transpl Infect Dis
Hayek H, Hasan L, Amarin JZ, Qwaider YZ, Hamdan O, Rezende W, Dee KC, Chappell JD, Halasa NB.   +8 more
europepmc   +1 more source

Bordetella trematum bacteraemia secondary to an empyema in an immunocompromised host: A case report and review of the literature. [PDF]

Access Microbiol, 2023
Wong C, Calungsud LG, La MV.
europepmc   +1 more source

Acyclovir‐Resistant Herpes Simplex Virus in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Series

Transplant Infectious Disease, EarlyView.
This retrospective case series of acyclovir‐resistant HSV infection in pediatric patients undergoing allogeneic HSCT discusses the clinical course, associated complications, and treatment, including side effects. We propose the first algorithm for investigating and managing acyclovir‐resistant HSV infections in pediatric HSCT recipients, highlighting ...
Jenna Nunn, Ahmed Ahmed, Srividhya Senthil, Oana Mirci‐Danicar, Denise Bonney, Claire Horgan, Omima Mustafa, Robert Wynn, Malcolm Guiver, Ramya Nataraj   +9 more
wiley   +1 more source

Chronic and reactivated dengue infection in an immunocompromised host: insights from a case report. [PDF]

Trop Med Health
Di Ascia L, Frumence E, Traversier N, Saint-Pastou C, Grard G, Vacher-Coponat H, de Lamballerie X, Jaffar-Bandjee MC.   +7 more
europepmc   +1 more source

SARS-CoV-2 in an immunocompromised host: convalescent plasma therapy and viral evolution elucidated by whole genome sequencing. [PDF]

BMJ Case Rep, 2023
Seth-Smith H, Vesenbeckh S, Egli A, Ott S.   +3 more
europepmc   +1 more source

Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney‐Transplant and Hematopoietic Cell Transplant Recipients

Transplant Infectious Disease, EarlyView.
Third‐party, BK virus‐specific cytotoxic T lymphocytes (CTLs) were safe and effective in reducing viremia in kidney and stem cell transplant recipients with BK virus nephropathy. However, they did not improve kidney function. Earlier administration may be more beneficial before nephropathy and irreversible damage occur.
Amanda Olson, Ye Ethan Li, Rafet Basar, Pinaki Banerjee, Indresh Kaur, Glorette Abueg, Melihate Sylejmani, Nadima Uprety, Rejeena Shrestha, Francia Reyes Silva, Valda Page, Richard E. Champlin, Dimitrios P. Kontoyiannis, Roy F. Chemaly, Elizabeth J. Shpall, Linda Moore, Osama A. Gaber, Katayoun Rezvani, Ala Abudayyeh   +18 more
wiley   +1 more source

Editorial: Microbiome in an immunocompromised host- a jungle of challenges or a glacier of hidden opportunities? [PDF]

Front Cell Infect Microbiol
Wojciuk B, Falcone EL, Lawson R.
europepmc   +1 more source